Market Cap : 435.35 M | Enterprise Value : 408.07 M | PE Ratio : 17.11 | PB Ratio : 8.64 |
---|
NAS:CODX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CODX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Co-Diagnostics's quarterly additional paid-in capital increased from Mar. 2020 ($45.17 Mil) to Jun. 2020 ($46.73 Mil) and increased from Jun. 2020 ($46.73 Mil) to Sep. 2020 ($48.04 Mil).
Co-Diagnostics's annual additional paid-in capital increased from Dec. 2017 ($16.26 Mil) to Dec. 2018 ($17.62 Mil) and increased from Dec. 2018 ($17.62 Mil) to Dec. 2019 ($26.69 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.
Additional Paid-In Capital is calculated as
Additional Paid-In Capital | = | (Issue Price | - | Par Value) | * | Shares Outstanding (Diluted Average) |
No Headline